RFC5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.935600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.928800E-01
Normal-vs-Stage2
7.398000E-01
Normal-vs-Stage3
7.564500E-02
Normal-vs-Stage4
8.435000E-01
Stage1-vs-Stage2
8.851600E-01
Stage1-vs-Stage3
1.607630E-01
Stage1-vs-Stage4
7.986800E-01
Stage2-vs-Stage3
1.039550E-01
Stage2-vs-Stage4
8.736200E-01
Stage3-vs-Stage4
6.374000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.621400E-01
Normal-vs-AfricanAmerican
3.011800E-01
Normal-vs-Asian
2.098800E-01
Caucasian-vs-AfricanAmerican
4.616000E-01
Caucasian-vs-Asian
1.602040E-01
AfricanAmerican-vs-Asian
6.972800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.429200E-01
Normal-vs-Female
6.394000E-01
Male-vs-Female
7.419200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.399410E-01
Normal-vs-Age(41-60Yrs)
9.724200E-01
Normal-vs-Age(61-80Yrs)
5.556000E-01
Normal-vs-Age(81-100Yrs)
8.174200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.620250E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.675400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.682600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.897600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.911800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.796400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.159400E-01
Normal-vs-Daily Drinker
6.814400E-01
Normal-vs-Weekly Drinker
7.640000E-01
Normal-vs-Occasional Drinker
8.663800E-01
Normal-vs-Social Drinker
7.730000E-01
Non Drinker-vs-Daily Drinker
7.148000E-01
Non Drinker-vs-Weekly Drinker
7.533200E-01
Non Drinker-vs-Occasional Drinker
1.182430E-01
Non Drinker-vs-Social Drinker
4.150800E-01
Daily Drinker-vs-Weekly Drinker
9.808000E-01
Daily Drinker-vs-Occasional Drinker
2.785800E-01
Daily Drinker-vs-Social Drinker
6.923200E-01
Weekly Drinker-vs-Occasional Drinker
4.085400E-01
Weekly Drinker-vs-Social Drinker
7.821800E-01
Occasional Drinker-vs-Social Drinker
4.606600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.627000E-01
Normal-vs-Grade 2
8.169400E-01
Normal-vs-Grade 3
8.594600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.289170E-01
Grade 1-vs-Grade 3
3.031500E-02
Grade 1-vs-Grade 4
7.627000E-01
Grade 2-vs-Grade 3
2.119400E-01
Grade 2-vs-Grade 4
8.169400E-01
Grade 3-vs-Grade 4
8.594600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.044800E-01
Normal-vs-NonDiabetic
6.737600E-01
Diabetic-vs-NonDiabetic
6.775400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.592200E-01
Normal-vs-NoPancreatitis
6.794600E-01
Pancreatitis-vs-NoPancreatitis
5.213800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.842600E-01
Normal-vs-N1
7.322200E-01
N0-vs-N1
9.666200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.340600E-01
Normal-vs-TP53-NonMutant
8.888200E-01
TP53-Mutant-vs-TP53-NonMutant
9.458300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
